Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2024 | 10-2023 | 07-2023 | 04-2023 | 01-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,677 | -6,616 | 20,288 | -37,142 | -21,955 |
| Depreciation Amortization | 537 | 270 | 2,682 | 2,076 | 1,428 |
| Accounts receivable | 1,252 | 2,019 | 5,033 | 1,861 | 653 |
| Accounts payable and accrued liabilities | -7,097 | -5,601 | 1,159 | 5,128 | 4,678 |
| Other Working Capital | -15,267 | -9,510 | 18,558 | 13,922 | 5,002 |
| Other Operating Activity | 7,940 | 6,064 | -84,696 | -5,790 | -4,697 |
| Operating Cash Flow | $-22,312 | $-13,374 | $-36,976 | $-19,945 | $-14,891 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -279 | -254 | -2,760 | -2,187 | -1,521 |
| Other Investing Activity | 0 | 0 | 101,740 | 0 | 0 |
| Investing Cash Flow | $-279 | $-254 | $98,980 | $-2,187 | $-1,521 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 23,846 | 7,565 | N/A |
| Debt Repayment | -73 | -51 | -4,136 | -253 | -157 |
| Common Stock Issued | N/A | N/A | 400 | 14 | N/A |
| Other Financing Activity | -467 | -467 | -21,235 | -4,211 | 0 |
| Financing Cash Flow | $-540 | $-518 | $-1,125 | $3,115 | $-157 |
| Exchange Rate Effect | -1 | -20 | -109 | 46 | 20 |
| Beginning Cash Position | 83,373 | 83,373 | 22,603 | 22,603 | 22,603 |
| End Cash Position | 60,241 | 69,207 | 83,373 | 3,632 | 6,054 |
| Net Cash Flow | $-23,132 | $-14,166 | $60,770 | $-18,971 | $-16,549 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,312 | -13,374 | -36,976 | -19,945 | -14,891 |
| Capital Expenditure | -279 | -254 | -2,760 | -2,187 | -1,521 |
| Free Cash Flow | -22,591 | -13,628 | -39,736 | -22,132 | -16,412 |